Moving one step closer to catching the GH cheats: The GH-2004 experience

Growth Hormone and IGF Research

Volumn 19, Issue 4, 2009, Pages 346-351

  Holt, Richard I G ^a   Bassett, E Eryl ^b   Erotokritou Mulligan, Ioulietta ^a   McHugh, Cathy ^a   Cowan, David ^c   Bartlett, Christiaan ^c   Sönksen, Peter H ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF KENT   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Abuse; Biomarker; GH; IGF I; P III P; Sport

Indexed keywords

COLLAGEN TYPE 3; EDETIC ACID; HUMAN GROWTH HORMONE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ARTICLE; ATHLETE; ATHLETIC PERFORMANCE; BONE METABOLISM; COLLAGEN SYNTHESIS; DOPING; ETHNIC DIFFERENCE; FRACTURE HEALING; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; PRESERVATION AND STORAGE; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SPORT INJURY; STORAGE TEMPERATURE; VALIDATION PROCESS;

ATHLETES; BIOLOGICAL MARKERS; DOPING IN SPORTS; EUROPE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERNATIONAL COOPERATION; MALE; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROTEIN ISOFORMS; RECOMBINANT PROTEINS; SPECIMEN HANDLING; SUBSTANCE ABUSE DETECTION;

EID: 67749084114     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2009.04.012     Document Type: Article

References (23)

1. Holt R.I., and Sonksen P.H. Growth hormone, IGF-I and insulin and their abuse in sport. Br. J. Pharmacol. 154 3 (2008) 542-556
2. Powrie J.K., Bassett E.E., Rosen T., Jorgensen J.O., Napoli R., Sacca L., et al. Detection of growth hormone abuse in sport. Growth Horm. IGF Res. 17 3 (2007) 220-226
3. World Anti-Doping Agency. International Standard for Laboratories Version 5.0. . 2008. (Accessed 13 May 2009).
4. Healy M.L., Dall R., Gibney J., Bassett E., Ehrnborg C., Pentecost C., et al. Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting. J. Clin. Endocrinol. Metab. 90 2 (2005) 641-649
5. Erotokritou-Mulligan I., Bassett E.E., Cowan D., Bartlett C., McHugh C., Sonksen P.H., et al. Influence of ethnicity on insulin like growth factor-I and procollagen III peptide in elite athletes and its effect on the ability to detect GH abuse. Clin. Endocrinol. 70 1 (2009) 161-168
6. Bagg W., Aoina J., Cross P.A., Whalley G.A., Gamble G.D., Doughty R.N., et al. Serum IGF-I levels are similar in Samoan, Maori and European populations despite differences in body composition. Growth Horm. IGF Res. 16 1 (2006) 57-60
7. DeLellis K., Ingles S., Kolonel L., Kean-Cowdin R., Henderson B., Stanczyk F., et al. IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br. J. Cancer 88 2 (2003) 277-282
8. McGreevy K., Hoel B., Lipsitz S., Bissada N., and Hoel D. Racial and anthropometric differences in plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein-3. Urology 66 3 (2005) 587-592
9. Nelson A.E., Howe C.J., Nguyen T.V., Leung K.C., Trout G.J., Seibel M.J., et al. Influence of demographic factors and sport type on growth hormone-responsive markers in elite athletes. J. Clin. Endocrinol. Metab. 91 11 (2006) 4424-4432
10. Dall R., Longobardi S., Ehrnborg C., Keay N., Rosen T., Jorgensen J.O., et al. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. J. Clin. Endocrinol. Metab. 85 11 (2000) 4193-4200
11. Longobardi S., Keay N., Ehrnborg C., Cittadini A., Rosen T., Dall R., et al. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group. J. Clin. Endocrinol. Metab. 85 4 (2000) 1505-1512
12. Erotokritou-Mulligan I., Bassett E.E., Bartlett C., Cowan D., McHugh C., Seah R., et al. The effect of sports injury on insulin like growth factor-I and procollagen III peptide: implications for detection of growth hormone abuse in athletes. J. Clin. Endocrinol. Metab. 93 7 (2008) 2760-2763
13. Mesotten D., and Van den B.G. Changes within the growth hormone/insulin-like growth factor I/IGF binding protein axis during critical illness. Endocrinol. Metab. Clin. North Am. 35 4 (2006) 793-805
14. Stoffel K., Engler H., Kuster M., and Riesen W. Changes in biochemical markers after lower limb fractures. Clin. Chem. 53 1 (2007) 131-134
15. Joerring S., Krogsgaard M., Wilbek H., and Jensen L.T. Collagen turnover after tibial fractures. Arch. Orthop. Trauma Surg. 113 6 (1994) 334-336
16. Kurdy N.M. Serology of abnormal fracture healing: the role of PIIINP, PICP, and BsALP. J. Orthop. Trauma 14 1 (2000) 48-53
17. Kniess A., Ziegler E., Kratzsch J., Thieme D., and Muller R.K. Potential parameters for the detection of hGH doping. Anal. Bioanal. Chem. 376 5 (2003) 696-700
18. Erotokritou-Mulligan I., Bassett E.E., Kniess A., Sonksen P.H., and Holt R.I. Validation of the growth hormone (GH)-dependent marker method of detecting GH abuse in sport through the use of independent data sets. Growth Horm. IGF Res. 17 5 (2007) 416-423
19. Zhang D.J., Elswick R.K., Miller W.G., and Bailey J.L. Effect of serum-clot contact time on clinical chemistry laboratory results. Clin. Chem. 44 6 (Pt 1) (1998) 1325-1333
20. Holt R.I., Erotokritou-Mulligan I., Ridley S.A., McHugh C.M., Bassett E.E., Cowan D.A., et al. A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide. Growth Horm. IGF Res. 19 1 (2009) 43-50
21. GH-2000 project team GH2000 A methodology for the detection of doping with growth hormone and related substance. . (Accessed 14 May 2009).
22. Hoelzel W., Weykamp C., Jeppsson J.O., Miedema K., Barr J.R., Goodall I., et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin. Chem. 50 1 (2004) 166-174
23. Abellan R., Ventura R., Pichini S., Pascual J.A., Pacifici R., di C.S., et al. Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport. Clin. Chem. Lab. Med. 43 1 (2005) 75-85